Abstract: Macrophages are vital for host defense against microbial infections. We have previously shown that infection of macrophages with a nonpathogenic strain of Escherichia coli induces apoptosis rapidly. Here, we demonstrate that infection of macrophages results in the activation of caspases prior to the induction of the intrinsic apoptosis pathway. Caspases 9 and 3 are activated prior to the release of intermembrane mitochondrial protein cytochrome C into the cytosol in infected macrophages. Treatment with an inhibitor to caspase 9 has no effect on the death of macrophages and does not prevent activation of the downstream effector caspase 3/7. In contrast, an inhibitor to caspase 3/7 reduces cell death in E. coli-infected macrophages. Although caspase 9 is not required, activation of aspartic proteases, of which cathepsin D is one of the central members, is essential for activation of caspase 3/7. Treatment with pepstatin A, an inhibitor of aspartic proteases, markedly diminishes the activation of cathepsin D and caspase 3/7 and reduces death in E. coli-infected macrophages. Collectively, these data suggest that cathepsin D activation of caspase 3/7 may be required for inducing one of the death pathways elicited by E. coli. J. Leukoc. Biol. 81: 229 -237; 2007.
INTRODUCTION
Macrophages are necessary for the innate immune response to bacterial infections [1] . Activation of TLR has been shown to be an early response to bacterial infection (reviewed in ref. [2] ) and is necessary for phagocytosis and killing of bacteria. Macrophages from mice deficient in TLR4 or the adaptor protein MyD88 have reduced phagocytosis of bacteria and decreased bactericidal activity [3] . Depletion of macrophages results in decreased clearance of the pathogenic bacteria Yersinia in blood and increased bacterial load in liver [4] . Mice with impaired recruitment of macrophages to sites of Escherichia coli infection have increased bacterial loads in liver and/or increased mortality [5, 6] . Phagocytosis of bacteria, regardless of its pathogenicity, has been shown to induce macrophage apoptosis [7] [8] [9] , which results in decreased antigen presentation [10] , inflammatory response [11] , and bacterial clearance [11] . Mice transgenic for the antiapoptotic protein Bcl-2 in myeloid cells have increased survival and have reduced bacterial loads within the peritoneum in the cecal ligation and puncture model of sepsis [12] . These data demonstrate that phagocytosis, recruitment, and survival of macrophages are all necessary to control bacterial infection.
The majority of apoptotic events is initiated by ligand binding to a death receptor on the cell surface ("extrinsic" pathway) or by activation/inactivation of intracellular factors, which induce the release of inner mitochondrial proteins ("intrinsic" pathway). Death receptor binding to its ligand induces the recruitment of Fas-associated death domain and procaspase 8, which results in the autocatalysis/activation of procaspase 8 [13] . The intrinsic pathway is regulated by the Bcl-2 protein family, which is divided into antiapoptotic (Bcl-2, Bcl-x L , Mcl-1, A1/Bfl-1, and Bcl-w) and proapoptotic (Bax, Bak, Bad, Bim/Bod, Bok/Mtd, Bik/Blk/Nbk, Bid, Hrk/DP5, Bmf, Noxa, and Puma/Bbc3) members [14] . Apoptosis signaling through the intrinsic pathway may be inhibited by overexpression of any Bcl-2-like prosurvival family members [15] [16] [17] or by loss of multi-Bcl-2-homology domain proteins Bak and Bax [18 -21] . During intrinsic apoptosis signaling, the integrity of the outer mitochondrial membrane is lost [22] , and apoptogenic mitochondrial intermembrane proteins, such as cytochrome C, are released into the cytosol [23, 24] . The association of cytochrome C with the adaptor protein Apaf-1 and procaspase 9 leads to the catalysis of the zymogen isoform of caspase 9, which then activates the effector caspases 3, 6, and 7 [25] , which induce the downstream, degradative events in apoptosis [26] .
Infection with bacteria, regardless of pathogenicity, may induce macrophages to undergo apoptosis [27] . The mecha-nisms of apoptosis mediated by pathogenic bacteria, including pathogenic species of E. coli, have been investigated extensively and are generally attributed to secretion or injection of toxic protein(s) expressed by the bacteria [28 -35] . Unlike pathogenic bacteria, few studies have examined the mechanism of apoptosis induced by nonpathogenic E. coli in macrophages [8, 9, 11] . Although the Bcl-2 family and activation of caspases [8, 9, 11] have been shown to contribute to the death of E. coli-infected macrophages, here, we show an essential role for caspase 3/7 in the death of macrophages following infection with E. coli. Activation of caspase 3/7 but not 9 is required for apoptosis of macrophages following infection with E. coli. Treatment with an inhibitor to aspartic proteases, which includes cathepsin D, a lysosomal protease that has been shown to induce the activation of caspase 3 [36 -45] , decreases the activity of caspase 3/7 and reduces the number of apoptotic macrophages following infection with E. coli. These data indicate that in macrophages, aspartic proteases such as cathepsin D but not the cysteine protease caspase 9 are responsible for activation of caspase 3/7, an essential factor for E. coli-induced apoptosis.
MATERIALS AND METHODS

Cell culture
E. coli K12 strain DH5␣ (Invitrogen, Carlsbad, CA), transformed with an expression construct for enhanced GFP (a gift from Georg Hacker, Technische Universitat Muchen, Munich, Germany) or with pBS-SKϪ/Ϫ (Stratagene, La Jolla, CA), was inoculated from a frozen stock or from an agar plate into liquid Luria-Bertani (LB) medium containing ampicillin. E. coli was incubated at 37°C until reaching an OD between 0.5 and 0.8. E. coli was collected by centrifugation, washed with PBS, and resuspended in RPMI-1640 media. Quantification of E. coli per mL RPMI was determined by dilution of the cultures and counting formation of colonies. Phorbolesters (10 M, Sigma Chemical Co., St. Louis, MO) were added to human monocytic cells (THP-1) for 18 -24 h to induce differentiation into macrophages and cell cycle arrest [46, 47] . Human primary macrophages were derived from peripheral blood monocytes as described previously [48] . Macrophages were cultured in RPMI 1640/10% heat-inactivated FBS/50 M 2-ME (Invitrogen). As a dose response curve revealed that the LD 50 for nonpathogenic E. coli is at a ratio of 25:1 bacterial:cell (Supplemental Fig. 1 ), macrophages were infected with E. coli at 25:1 bacteria:cell in antibiotic-free media containing 10% heat-inactivated FBS as described previously [11] . Gentamicin (200 g/mL, Invitrogen) was added to kill all external bacteria after 2 h of incubation. BenzyloxycarbonylVal-Ala-Asp-fluoromethylketone (zVAD.fmk; 10 M), z-Asp-Glu-Val-Asp .fmk (zDEVD.fmk; 20 M), z-Leu-Glu-His-Asp.fmk (zLEHD.fmk; 20 M, BD PharMingen, San Diego, CA), pepstatin A (100 M), or N-acetyl-Leu-LeuNorleu-al (ALLN; 50 M, Sigma Chemical Co.) was added to macrophages prior to infection with E. coli to inhibit caspase or cathepsin activity. Macrophages were UV-irradiated at 50 mJ/cm 2 using a UV-Stratalinker 1800 (Stratagene Inc.).
Apoptosis assays
Macrophages were removed from plates by incubation with accutase (eBiosciences, San Diego, CA), stained with Annexin V conjugated to allophycocyanin (APC; Caltag, Burlingame, CA) and 7-amino-actinomycin (7-AAD; BD PharMingen), and acquired on FACSCalibur (BD PharMingen) using CellQuest software at the Saint Louis University Core Flow Cytometry Facility (MO). All analysis was performed using FlowJo software (Tree Star Inc., Ashland, OR). To determine the activities of caspases 9 and 3/7 or cathepsin D, whole cell extracts from macrophages were harvested at various time-points following infection, and equal amounts of protein were analyzed for protease activity, as described by the manufacturers (Chemicon, Temecula, CA, and Calbiochem, San Diego, CA). The Cell Death ELISA Plus kit (Roche, Indianapolis, IN) was used to measure DNA fragmentation. Briefly, the cytoplasmic fraction of cell lysates was incubated in antihistone-coated microtiter plates to bind mono-and oligonucleosomal DNA. Histone-bound DNA was detected with a peroxidase-conjugated anti-DNA antibody and quantified by absorbance on a microplate reader (BioRad, Hercules, CA).
Immunoblot analysis
Whole cell extracts were prepared as described previously [49] from uninfected and infected cultures. Cytoplasmic and mitochondrial-enriched extracts were prepared by incubating cells in a lysis buffer (220 mM mannitol, 68 mM sucrose, 50 mM PIPES-KOH, pH 7.4, 50 mM KCl, 2 mM MgCl 2 , 1 mM EDTA, 1 mM dithiothreitol, and a cocktail of protease inhibitors) for 10 min on ice followed by homogenization with a glass dounce and a B pestle (60 -70 strokes). Cell homogenates were spun at 200 g for 5 min, and supernatants were removed and spun at 14,000 g for 15 min. Pellet (mitochondrial) and supernatant (cytoplasmic) fractions were stored at -80°C. Whole cell or enriched extracts (40 g) and molecular weight markers (Invitrogen) were analyzed by PAGE on 4 -12.5% polyacrylamide gels containing SDS and transferred to Immobilon-P (Millipore Corp., Bedford, MA) by semidry blotting. 
Colony formation assays
Colony formation assays were performed as described previously [11] . Briefly, macrophages infected with GFP-E. coli were washed four times with PBS, incubated with gentamicin (200 g/mL) for at least 30 min, and then lysed with 1 mL water for 10 min. The lysate was serially diluted, cultured on LB plates containing ampicillin, and incubated at 37°C. Clearance of bacteria was assessed by counting the number of bacterial colonies/plate.
Statistics
Results were expressed as the mean Ϯ SE. Differences between groups were analyzed using a Student's t test.
RESULTS
Caspase activation occurs prior to the induction of the intrinsic apoptosis pathway in E. coliinfected macrophages
Previous studies have demonstrated that caspases and the Bcl-2 family of proteins have a role in the apoptosis of murine macrophages following infection with E. coli [8, 9] . Although these studies suggest that the apoptosis is mediated through the mitochondria, they have not determined directly how infection affects the levels of Bax, Bim, or cytochrome C. Therefore, we infected PMA-differentiated THP-1 macrophages with E. coli and determined the levels of Bax, Bim, or cytochrome C in cytoplasm or mitochondria over time. Whereas the levels of Bax in mitochondria and cytoplasm remained constant over time, the levels of the long Bim (BimL) isoform increased in mitochondria and decreased in the cytoplasm at 1.5 h following infection of macrophages with E. coli (Fig. 1) . Subsequent to BimL translocation to the mitochondria, cytochrome C was released into the cytoplasm at 3 h post-E. coli infection (Fig. 1) . In contrast, irradiation of macrophages with UV light induced a rapid increase in the level of cytochrome C in the cytoplasmic fraction (Supplemental Fig. 2 ), which preceded activation of caspases 9 and 3/7 (data not shown). As our previous study demonstrated that caspases 9 and 3/7 are activated at 1.5 h following infection [11] and as cytochrome C release is not apparent until 3 h postinfection, these data suggest that activation of caspases 9 and 3/7 precedes the induction of the intrinsic apoptotic pathway in E. coli-infected macrophages.
Caspase 9 activation is not required for macrophage apoptosis following infection with E. coli
Although infection of macrophages with E. coli results in the activation of caspases 9 and 3/7, caspase 9 is not essential for apoptosis mediated by the intrinsic pathway [50 -53] . Therefore, we examined the role of caspase 9 in the activation of caspase 3/7 and apoptosis of macrophages following infection. Pretreatment of macrophages with zLEHD.fmk, an inhibitor to caspase 9, blocked the activity of caspase 9 ( Fig. 2A) but only had a minor effect on activation of caspase 3 (28% reduction; Fig. 2B ) and had no effect on the survival of infected macrophages (Fig. 2C) . In contrast, pretreatment with zLEHD.fmk suppressed the activity of caspases 9 and 3/7 and increased survival of macrophages irradiated with UV light (Supplemental Fig. 3) , a known inducer of apoptosis, which proceeds through the intrinsic, apoptosis pathway [54, 55] . These data indicate that activity of caspase 9 is dispensable for apoptosis induced by E. coli but is necessary for cell death of macrophages induced by UV. Further, these data suggest that E. coli induces a caspase 9-dependent and -independent activation of caspase 3.
Suppression of caspase 3/7 activity reduces apoptosis and enhances clearance of E. coli by macrophages
Although caspase 3/7 is activated early in E. coli-infected macrophages, we examined the effect of inhibiting caspase 3/7 on apoptosis of macrophages. Pretreatment with zDEVD.fmk increased the survival of macrophages infected with E. coli by 55% (Fig. 3, A and B) . Further, pretreatment with zDEVD. fmk decreased the number of macrophages that were Annexin V ϩ /7AAD
-and Annexin V ϩ /7AAD ϩ by 35% (PϽ0.001) and decreased DNA fragmentation by 47% as compared with macrophages infected with E. coli (Fig. 3, A, C, and D) . A similar decrease in DNA fragmentation was seen in macrophages derived from human peripheral blood monocytes (see Fig. 6B ). Macrophages pretreated with zVAD.fmk, a general caspase inhibitor, displayed a comparable level of survival as cells pretreated with the caspase 3/7 inhibitor (Fig. 3, B-D) . Pretreatment with zDEVD.fmk enhanced the rate of clearance of Fig. 1 . Caspase activation occurs prior to induction of the intrinsic apoptosis pathway in macrophages infected with E. coli. THP-1 macrophages were infected with E. coli at a ratio of 25:1, and cells were harvested at various times following infection. Immunoblot analyses of cytochrome C, Bax, and Bim were performed using mitochondrial or cytoplasmic extracts. ␣-Tubulin and subunit IV of cytochrome C oxidase (COX 4) levels were assessed to examine the purity of the extracts. Bim S , Short Bim. Fig. 2 . Caspase 9 activity is dispensable for activation of caspase 3/7 and apoptosis in macrophages following infection with E. coli. THP-1 macrophages were infected with E. coli in the presence or absence of zLEHD.fmk. (A) Activities of caspase 9 or (B) caspase 3/7 were assessed at 1.5 h following infection. (C) Percent survival of macrophages was assessed by flow cytometry using Annexin V-APC and 7AAD at 6 h postinfection. Values represent the average Ϯ SEM of three experiments performed in triplicate, which were compared by Student's t test. *, P Ͻ 0.01, as compared with untreated macrophages; **, P Ͻ 0.04, as compared with parallel, E. coli-infected macrophages. ns, Not statistically significant. viable bacteria over time (Fig. 3E) . These data are consistent with a previous study demonstrating that pretreatment with zVAD.fmk increased the rate of clearance of bacteria [11] . Collectively, our data indicate that caspase 3/7 is an essential factor for apoptosis of macrophages infected with E. coli and for enhancing the rate of E. coli clearance.
Caspase 3/7 activates caspase 9 in macrophages infected with E. coli
Our data demonstrate that activity of caspase 3/7 but not caspase 9 is necessary for apoptosis of macrophages following infection. It is interesting that caspase 9 may be activated by caspase 3 [56, 57] . Therefore, we examined the role of caspase 3 in the activation of caspase 9 in macrophages following infection. Pretreatment with zDEVD.fmk completely inhibited the activity of caspases 3/7 and 9 in E. coli-infected macrophages (Fig. 4, A and B) . Further, zDEVD.fmk reduced the appearance of the active isoform of caspase 3 (p18) and caspase 9 (p35) in E. coli-infected THP-1 macrophages (Fig.  4C ) and human monocyte-derived macrophages (data not shown). In contrast, although zDEVD.fmk completely inhibited the activity of caspase 3/7 in macrophages following UV irradiation (Supplemental Fig. 4A ), the activity of caspase 9 was only reduced partially (Supplemental Fig. 4B ). These data suggest that caspase 9 may be activated by caspase 3 through a feedback loop mechanism as described previously [58] . To confirm that zDEVD.fmk does not inhibit caspase 9 directly, addition of zDEVD.fmk to extracts from UV-treated cells revealed a minor reduction of activity of caspase 9 (Ͻ9%), and addition of zLEHD.fmk almost completely abolished the activity of caspase 9 activity (Ͼ92%; Supplemental Fig. 4C ). Collectively, these data indicate that caspase 3 induces the activation of caspase 9 in macrophages following infection with E. coli.
The aspartic protease cathepsin D is associated with apoptosis and activation of caspase 3/7 in E. coli-infected macrophages As our data indicate that caspase 9 is not required for the death of macrophages or for the activation of caspase 3/7 following infection with E. coli and as cathepsins have been shown to induce the activation of caspase 3 and are activated following bacterial infections [36 -41] , we examined the role that cathepsins have in the apoptosis of macrophages and in the activation of caspase 3/7 following infection with E. coli. There was a decrease in the inactive zymogen isoform of cathepsin D at 1.5 h postinfection (Fig. 5A) , which corresponded with a 41% (PϽ0.01) increase in activity of cathepsin D (Fig. 5B) . Pre- Fig. 4 . Caspase 3/7 activity is required for activation of caspase 9 following E. coli infection in THP-1 macrophages, which were infected with E. coli at a ratio of 25:1 in the presence or absence of zDEVD.fmk. (A/B) Activity of caspase 3/7 was assessed at 1.5 h following infection with E. coli. Values represent the average Ϯ SEM of five experiments performed in triplicate, which were compared by Student's t test. *, P Ͻ 0.01, as compared with untreated control; **, P Ͻ 0.04, as compared with parallel, E. coli-infected macrophages. (C) Immunoblot analysis of active caspase 9 and active caspase 3 was performed on whole cell extracts. ␣-Tubulin levels were assessed as a loading control. Data are representative of three independent experiments. (Fig. 5, A and B) . Treatment with pepstatin A markedly reduced Annexin V staining by 48% (PϽ0.01) and DNA fragmentation by 54% (PϽ0.01) following E. coli infection (Fig. 6, A and B) . In contrast, pretreatment with ALLN, an inhibitor of cathepsin B and L [60, 61] , had no effect on apoptosis in macrophages following infection (Fig. 6A) . Further, the combination of pepstatin A and DEVD.fmk had no additive effect on suppressing E. coli-induced macrophage apoptosis (data not shown). These data suggest that cathepsin D activity but not cathepsin B or L contributes to apoptosis following E. coli infection.
To further investigate the effect of pepstatin A in apoptosis of macrophages following infection with E. coli, we examined the activation of caspase 3/7. Pretreatment with pepstatin A reduced caspase 3/7 activity by 47%, 44%, and 50% (PϾ0.01), respectively, at 1.5, 3.0, and 6.0 h following E. coli infection (Fig. 6C) . Furthermore, pepstatin A markedly reduced the appearance of the active caspase 3 isoform following infection with E. coli (Fig. 6D) . In contrast, zDEVD.fmk had no effect on the maturation of cathepsin D in macrophages infected with nonpathogenic E. coli (Fig. 6E) . These data indicate that caspase 3 activation is downstream of activation of aspartic proteases including cathepsin D. Taken together, these data indicate that E. coli infection induces the activation of cathepsin D, which leads to activation of caspase 3/7 and the downstream degradative events of apoptosis.
DISCUSSION
Apoptosis of macrophages following infection with nonpathogenic E. coli involves the Bcl-2 family and the activation of caspases 9 and 3/7 [9, 11] . Here, we show that although infection of macrophages with the nonpathogenic E. coli induces the activation of the intrinsic apoptosis pathway, activa- tion of caspase 3/7 does not require caspase 9. Instead, we demonstrate that activation of caspase 3 and subsequent cell death are likely mediated by cathepsin D. Although pepstatin A may inhibit additional aspartic proteases including cathepsin E, pepsin, or renin [62] , the majority of the effects of pepstatin A has been attributed to its inhibition of cathepsin D, which is the major intracellular, aspartic protease [63] . However, our data do not exclude the possibility of additional aspartic proteases having an effect on the apoptosis of macrophages following infection with E. coli. Future studies will be needed to examine the contribution of other aspartic proteases in addition to cathepsin D in apoptosis of macrophages following infection with E. coli.
Our data are consistent with the fact that caspase 3/7 is activated prior to cytochrome C release and that the inhibition of caspase 3/7 activity blocks the activity of caspase 9. Caspase 3/7 is downstream of cathepsin D, as inhibition of caspase 3/7 has no effect on the activation of cathepsin D. Thus, caspase 9 may function as an enhancer for the activation of caspase 3/7 during infection with E. coli, as there is a minor decrease in the activity of caspase 3/7 following pretreatment with a caspase 9 inhibitor. However, caspase 9 is dispensable for the apoptosis of macrophages following infection with E. coli. This is consistent with previous studies that have shown that activation of caspase 9 is not always required for apoptosis induced through the intrinsic apoptosis pathway, as cells deficient in Apaf-1 or caspase 9 still undergo apoptosis and have activation of the downstream effector caspases [50 -52] . Collectively, our data suggest a novel role for aspartic proteases, including cathepsin D, in the activation of caspase 3 and inducing apoptosis of macrophages following infection with a nonpathogenic species of E. coli.
The apoptotic response of macrophages plays a vital role in the pathogenesis of sepsis [12, 64, 65] . As inactivation of caspase 3 using caspase 3-deficient mice or caspase 3/7 inhibitors results in reduced development of sepsis [66] , these data suggest that suppression of caspase 3 and apoptosis is vital for clearance of bacteria during sepsis. Although the role of cathepsin D in the development of sepsis has yet to be elucidated, patients with severe sepsis often exhibit high levels of acid sphingomyelinase (ASMase) [67] , an upstream activator of cathepsin D [68 -70] . Treatment with inhibitors to ASMase decreases the activation of cathepsin D, improves the survival of mice injected with LPS, and reduces apoptosis of dendritic cells infected with E. coli [67, 70] . Our data demonstrate that aspartic protease inhibitors suppress the level of apoptosis in E. coli-infected macrophages to a similar extent as caspase inhibitors [11] . As we can also infer that cathepsin D-mediated activation of caspase 3 may regulate NF-B through proteolytic cleavage [11] , these data indicate that cathepsin D and caspases are linked in the death and inflammation pathways. Further, pepstatin A reduces bacterial clearance to similar levels as an inhibitor to caspase 3/7 (Supplemental Fig. 5 ). Although initial clearance of E. coli following infection is enhanced markedly in macrophages pretreated with DEVD. fmk, clearance of bacteria at later time-points is less dependent on cell viability. These data suggest that clearance is not solely dependent on cellular survival, but preventing the death of the infected macrophage results in an increased rate of clearance of bacteria. Taken together, these data suggest that the fate of macrophages during a bacterial infection may be a critical determinant for dissemination of the disease and for the proper inflammatory response. Thus, cathepsin D may be a viable target for therapeutic intervention in preventing the development and/or progression of sepsis.
